Navigation Links
CVS Caremark Corporation Announces Consent Solicitation Relating to Its 6.125% Senior Notes Due August 15, 2016 (CUSIP NO. 126650 BE 9)
Date:8/9/2011

WOONSOCKET, R.I., Aug. 9, 2011 /PRNewswire/ -- CVS Caremark Corporation (NYSE: CVS) announced today that it is soliciting consents (the "Consent Solicitation") from the registered holders as of 5:00 p.m., New York City time on August 8, 2011 (the "Record Date") of its 6.125% Senior Notes due August 15, 2016 (the "Notes") to terminate the replacement capital covenant, which was entered into on May 25, 2007, for the benefit of the holders of the Notes in connection with the issuance of its 6.302% Enhanced Capital Advantaged Preferred Securities due 2062 (the "ECAPS").  Under the replacement capital covenant, CVS Caremark is prohibited from repurchasing, redeeming or repaying its ECAPS on or before June 1, 2047 unless a specified portion of the funds used to repay, redeem or repurchase the ECAPS are obtained by CVS Caremark through the sale of common stock or certain other equity or equity-like securities. The termination of the replacement capital covenant requires the consent of the holders of a majority in aggregate principal amount of the outstanding Notes (the "Requisite Consents").

(Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO)

CVS Caremark will make a cash payment to each holder of the Notes of $15.00 per $1,000 in principal amount of the Notes as to which a duly executed consent is delivered and not revoked on or prior to the expiration of the Consent Solicitation if the consent solicitation is successful and the replacement capital covenant is terminated. Consents may be revoked at any time up to the earlier of 5:00 p.m., New York City time, on August 22, 2011 and the time and date on which CVS Caremark receives the Requisite Consents.  Any consent payment due will be paid promptly after the expiration of the Consent Solicitation and termination of the replacement capital covenant. The Consent Solicitation will expire at 5:00 p.m., New York City time, on August 22, 2011, unless terminated or extended by CVS Caremark in its sole discretion. The Consent Solicitation is being made pursuant to a "Consent Solicitation Statement" dated today, which sets forth a more comprehensive description of the terms of the Consent Solicitation.  This press release is not a solicitation of consents to the proposed termination of the replacement capital covenant.  

Copies of the Consent Solicitation Statement and the consent form may be obtained by holders of the Notes from the Information and Tabulation Agent for the Consent Solicitation, D.F. King & Co., Inc., at (800) 949-2583 (toll-free).

Barclays Capital Inc. and RBS Securities Inc. are the Solicitation Agents for the Consent Solicitation.  Questions may be directed to Barclays Capital Inc., at (800) 438-3242 (toll-free) or (212) 528-7581 (collect) or RBS Securities Inc., at (877) 297-9832 (toll-free) or (203) 897-4825 (collect).

About the Company:

CVS Caremark is the largest pharmacy health care provider in the United States with integrated offerings across the entire spectrum of pharmacy care. We are uniquely positioned to engage plan members in behaviors that improve their health and to lower overall health care costs for health plans, plan sponsors and their members. CVS Caremark is a market leader in mail order pharmacy, retail pharmacy, specialty pharmacy, and retail clinics, and is a leading provider of Medicare Part D Prescription Drug Plans. As one of the country's largest pharmacy benefits managers (PBMs), we provide access to a network of approximately 65,000 pharmacies, including more than 7,300 CVS/pharmacy® stores that provide unparalleled service and capabilities. Our clinical offerings include our signature Pharmacy Advisor™ program as well as innovative generic step therapy and genetic benefit management programs that promote more cost effective and healthier behaviors and improve health care outcomes. General information about CVS Caremark is available through the Company's website at http://info.cvscaremark.com.

Forward-looking Statements:

This press release contains certain forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially. For these statements, the Company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. The Company strongly recommends that you become familiar with the specific risks and uncertainties outlined under the Risk Factors section in our Annual Report on Form 10-K for the year ended December 31, 2010 and under the section entitled "Cautionary Statement Concerning Forward-Looking Statements" in our most recently filed Quarterly Report on Form 10-Q.  


'/>"/>
SOURCE CVS Caremark Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CVS Caremark Study Finds Non-Adherent Heart Failure Patients Almost Twice as Likely to be Re-Hospitalized Within a Year
2. CVS Caremark Data Confirms Improved Outcomes for Women with Osteoporosis Who are Adherent to Therapy
3. CVS Caremark Launches Distribution of $3 million in Free Seasonal Flu Shot Vouchers to the Unemployed
4. CVS Caremark Celebrates Outstanding Pharmacy Care to Patients During American Pharmacists Month in October
5. CVS Caremark Undertakes Multi-Year Study to Improve Patient Medication Adherence
6. CVS Caremark Announces Updates to Flu Vaccine Program
7. CVS Caremarks MinuteClinic and Allina Hospitals & Clinics Form Strategic Partnership
8. CVS Caremark Corporation Increases Quarterly Dividend 15%
9. CVS Caremarks MinuteClinic Becomes First Retail Clinic Provider to Achieve Consecutive Accreditation Awards From The Joint Commission
10. CVS Caremark Names New Chief Human Resources Officer
11. CVS Caremark Corporation Announces Quarterly Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data derived ... Assessment of major trends with potential impact on the market ... of market segmentation which comprises of sub markets, regional and ...
(Date:6/23/2016)... 2016 , , , WHEN: ... 2016 , , , , LOCATION: , , , Online, ... , , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global ... Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager ... pharmaceutical industry is witnessing an exceptional era. Several new demand spaces, ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... , ... TopConsumerReviews.com recently awarded their highest five-star rating to Best Buy Eyeglasses, ... the United States and Canada wear eyeglasses. Once considered to be a purely functional ... a fashion statement. Even celebrities use glasses as a way of creating an iconic ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified ... be personalized through a fitness app. The fitness app plans to fix the two major ... only offer a one size fits all type program , They don’t eliminate ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from PsychTests.com reveals that behind ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
Breaking Medicine News(10 mins):